原发免疫性血小板减少症治疗进展

摘要

Primary immune thrombocytopenia is an autoimmune disease characterized by reduced platelets, accompanied by or without skin mucous bruises,epistaxis,internal bleeding,etc. Recent years,the treatment of primary immune thrombocytopenia developed very quickly, including the appearance of platelet receptor agonist - Eltrom-bopag. Here,we reviewed the treatment and research development of primary immune thrombocytopenia.%原发免疫性血小板减少症是一种获得性免疫介导的以血小板减少、伴或不伴皮肤黏膜瘀紫、鼻衄、内脏出血等为特征的自身免疫性疾病.近年来,原发免疫性血小板减少症的治疗进展迅速,尤其是血小板受体激动剂艾曲波帕的出现.本文就原发免疫性血小板减少症的治疗研究进展作一综述.